H1 23 Results Presentation
14 September 2023
Disclaimer
These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the "Company"), including with respect to the progress, timing and completion of the Company's development, the Company's ability to treat, attract, and retain patients and customers, its ability to engage consultants and GPs and to operate its business and increase referrals, the integration of prior acquisitions, the Company's estimates for future performance and its estimates regarding anticipated operating results, future revenues, capital requirements, shareholder structure and financing. In addition, even if the Company's actual results or development are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of the Company's results or developments in the future. In some cases, you can identify forward-looking statements by words such as "could,"
"should," "may," "expects," "aims," "targets," "anticipates," "believes," "intends," "estimates," or similar words. These forward-looking statements are based largely on the Company's current
expectations as of the date of this presentation and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievement expressed or implied by these forward-looking statements. In particular, the Company's expectations could be affected by, among other things, uncertainties involved in the integration of acquisitions or new developments, changes in legislation or the regulatory regime governing healthcare in the UK, poor performance by consultants who practice at our facilities, unexpected regulatory actions or suspensions, competition in general, the impact of global economic changes, and the Company's ability to obtain or maintain accreditation or approval for its facilities or service lines. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements made during this presentation will in fact be realised and no representation or warranty is given as to the completeness or accuracy of the forward-looking statements contained in these materials.
The Company is providing the information in these materials as of this date, and we disclaim any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
2
Zoom Webinar rules of engagement
All attendee lines are muted
The Chat function is disabled
Please submit your name and organisation using the Q&A function
Angus will moderate the session and unmute your line for you to ask your question
Any problems please email Laura.Young@spirehealthcare.com
3
Agenda
H1 23 Overview
Justin Ash, Chief Executive Officer
H1 23 Financial Review
Jitesh Sodha, Chief Financial Officer
Summary and Outlook
Justin Ash, Chief Executive Officer
Q&A
Any problems please email Laura.Young@spirehealthcare.com
4
H1 23 Overview
Justin Ash, Chief Executive Officer
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Spire Healthcare Group plc published this content on 14 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2023 07:32:07 UTC.